Evidence map›Paper›PMID 32838116›Full record

ReviewSleep and vigilance2020

Guidelines of the Indian Society for Sleep Research (ISSR) for Practice of Sleep Medicine during COVID-19.

Ravi Gupta, V Mohan Kumar, Manjari Tripathi, Karuna Datta, Manjunatha Narayana, Kripesh Ranjan Sarmah, Manvir Bhatia, Preeti Devnani, Sourav Das, Deepak Shrivastava and 4 more

Abstract readReview
In one paragraph

Review in Sleep and vigilance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Disrupted Sleep During a Pandemic.Sleep medicine clinics · 2022
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Status of the practice of sleep medicine in India during the COVID-19 pandemic.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Article
  7. Rationale for reverse-transcription polymerase chain reaction for SARS-CoV-2 screening in patients undergoing in-laboratory sleep studies.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Article
  8. Review
  9. Ethical considerations in neurology during the COVID-19 pandemic.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ravi GuptaDepartment of Psychiatry, All India Institute of Medical Sciences, Rishikesh, 249203 India.
V Mohan KumarDepartment of Physiology, All India Institute of Medical Sciences, New Delhi, 110029 India.
Manjari TripathiDepartment of Neurology, All India Institute of Medical Sciences, New Delhi, India.
Karuna DattaDepartment of Sports Medicine, Armed Forces Medical College, Pune, India.
Manjunatha NarayanaDepartment of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Kripesh Ranjan SarmahApollo Hospital, Guwahati, India.
Manvir BhatiaNeurology and Sleep Centre, New Delhi, India.
Preeti DevnaniCleveland Clinic, Abu Dhabi, UAE.
Sourav DasSomnos Sleep Clinic, Kolkata, India.
Deepak ShrivastavaDivision of Pulmonary, Critical Care and Sleep, Department of Medicine and Medical Director, SJGH Sleep Center, UC Davis School of Medicine, Sacramento, CA USA.
Rama Devi GourineniNeurology, Northwestern Feinberg School of Medicine, Chicago, USA.
Tripat Deep SinghSleep- Asia-Pacific, Philips Electronics, Singapore, Singapore.
Apar JindalInstitute of Heart and Lung Transplant, Gleneagles Global Health City, Cheran Nagar, Perumbakkam, Chennai, 600 100 India.
Hruda Nanda MallickDepartment of Physiology, All India Institute of Medical Sciences, New Delhi, 110029 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSleep services are assigned a non-essential status during COVID-19. The American Academy of Sleep Medicine strongly urges sleep clinicians to continue postponing non-urgent care until a later date, if such a recommendation is made by state officials due to local conditions. At the same time, one cannot ignore the fact that sleep is important for people's health and wellbeing. Therefore, to protect the health of the population, it is essential to find ways and means to continue the practice of sleep medicine even during the COVID-19 pandemic.

methodSocial environment and work ethics in sleep clinics and sleep laboratories in Asia, Africa, and Latin America are different from those in the US. Under these circumstances, the Indian Society for Sleep Research (ISSR) created a task force to develop guidelines for the practice of sleep medicine, not only for the Indian environment but also for other countries that are affected by the COVID-19 pandemic. The task force examined documents regarding practice of sleep medicine and associated specialities  during COVID-19 by various professional organizations and governmental authorities. The recommendations were examined for their applicability. Wherever gaps were identified, consensus was reached keeping in view the available evidences. OUTCOME AND RECOMMENDATIONS: The emphasis of the guidelines is on avoiding doctor to patient contact during the pandemic. Teleconsultation and other modes of audio-visuals can be used as modes for medical practice during the COVID-19 pandemic. However, in addition to the patient, the presence of a family member, or a reliable informant is recommended. Patients of most sleep disorders can be provided tele-aftercare service. ISSR guidelines also give a list of medications allowed to be prescribed during the first and the follow-up teleconsultation. Hospitals and clinics are slowly opening in India and many other countries. As sleep services resume operations, there is a need to find innovative ways to reduce contact with COVID-19 patients, follow personal protection guidelines, as well as social distancing. This article does discuss strategies for the safe conduct of Level 1 sleep studies. Home sleep testing, which had greater acceptance during the last few years, should be given more attention during the COVID-19 period. Once the decision to reopen the sleep laboratory and resume operations is made, the safety of the patients and office staff should become the major priority. The ISSR recommendation is to postpone and reschedule in-laboratory positive pressure therapy, but it mentions the considerations to be followed in emergency situations. At the same time, high clinical risk patients may be diagnosed on the basis of clinical findings, and without performing polysomnography or home sleep testing. However, at some point, there is a need to reinitiate the in-lab testing. In addition, daily assessment of the COVID-19 situation in the community, along with a review of the situation with local public health and the state health department is advised.

Indexed as

COVID-19Home sleep studyIn-lab testingLevel-1 sleep studyPandemicPersonal protective equipment (PPE)PolysomnographyPositive airway pressure (PAP)Sleep medicineTeleconsultationTitration

Identifiers

PMID32838116
PMCPMC7334897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.